Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer

Listen to Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, as they discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer.